Chargement en cours...
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
INTRODUCTION: The efficacy and safety of vedolizumab, a gut-selective α(4)β(7) integrin antibody, were demonstrated in the GEMINI 1 and GEMINI 2 clinical trials of adults aged 18–80 years. We investigated the efficacy and safety of vedolizumab in patients stratified by age from the GEMINI trials. ME...
Enregistré dans:
| Publié dans: | Adv Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Healthcare
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5331094/ https://ncbi.nlm.nih.gov/pubmed/28070861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0467-6 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|